Together, our findings suggest that PIKfyve inhibition impairs autophagy, upregulates surface MHC-I, and, thus, controls tumor growth in a CD8+ T cell- and MHC-I-dependent manner (Fig. 5H). Here, CD8A is linked to neoplasm.